INDOLENT SYSTEMIC MASTOCYTOSIS
Clinical trials for INDOLENT SYSTEMIC MASTOCYTOSIS explained in plain language.
Never miss a new study
Get alerted when new INDOLENT SYSTEMIC MASTOCYTOSIS trials appear
Sign up with your email to follow new studies for INDOLENT SYSTEMIC MASTOCYTOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial offers hope for debilitating mast cell disease symptoms
Disease control Recruiting nowThis study is testing whether an investigational drug called BLU-263 can better control symptoms in people with indolent systemic mastocytosis whose current treatments aren't working well enough. Researchers will compare BLU-263 plus standard symptom treatments against placebo pl…
Matched conditions: INDOLENT SYSTEMIC MASTOCYTOSIS
Phase: PHASE2, PHASE3 • Sponsor: Blueprint Medicines Corporation • Aim: Disease control
Last updated Apr 02, 2026 02:26 UTC
-
New drug study offers hope for people battling uncontrolled mast cell disease
Disease control Recruiting nowThis study is observing how well the medication avapritinib works for people with indolent systemic mastocytosis (ISM) in real-life medical settings. It will follow about 80 participants in Germany for up to two years, focusing on whether the drug improves their quality of life a…
Matched conditions: INDOLENT SYSTEMIC MASTOCYTOSIS
Sponsor: Blueprint Medicines Corporation • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC